To our knowledge, ours is the first study to date to investigate the effect of the two known functional MDM4 and MDM2 variants on the risk of developing subsequent primaries (as a proxy for risk for melanoma) and melanoma-specific survival and the first to identify sex-dependent associations in a large population-based cohort of melanoma cases. Here, MDM2 is linked to melanoma.